alternative-therapies.com No large scale blinded dose ranging Phase II or efficacy Phase III RCTs have been published, and no comprehensive peer reviewed human pharmacokinetic (PK) profile (oral vs injection absorption, bioavailability, distribution, metabolism, excretion) is available
AnagenX is the result of thatcombining GHK-Cu, BPC-157, and GHK-Biotin in one clean, powerful formula to support stronger, fuller, healthier hair
GHK-Cu is shorthand for the glycyl-L-histidyl-L-lysine copper complex , a small peptide made of three amino acids bound to a single copper ion
Animal studies have shown it to be cytoprotective against known carcinogens
Episode format: overview of common health topics based on listener questions [1:30]